Not authorised

Product identification

Medicine name:
Nafpenzal DC Intramammary Suspension
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Dihydrostreptomycin sulfate
    116.81
    milligram(s)
    /
    1.00
    Syringe
  • Nafcillin sodium
    105.31
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        48
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • Each 3 g syringe is made of low density polyethylene. The syringes are packed in a sachet. The sachet is packed in a carton. Cleaning towels packed in a sachet are also included in the carton. Packs of 20 syringes and 20 cleaning towels.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/074/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/04/2022
Download
Source URL: https://medicines.health.europa.eu/veterinary/600000064430